Parc 55, San Francisco
January 8, 2018 - January 10, 2018

TPP Healthcare to Offer 1:1 Meeting Space at JP Morgan and Biotech Showcase Healthcare Week

TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between US, Europe and China’s healthcare companies, in partnership with B. Riley FBR, Inc. and Citigate Dewe Rogerson Life Sciences, will be offering complimentary 1:1 meeting space to during the JP Morgan Healthcare Week for in invited on-site innovators and notable Asian healthcare investors from January 8-10, 2018 at Parc 55 in San Francisco. Sponsorship opportunities for the meeting space are available to deliver the greatest impact and visibility up to and throughout the conference targeting a unique group of cross-border investors and emerging healthcare technologies. All reservation requests can be made through by visiting our reservation site. Please contact Trisha Salerno at trisha.salerno@tpphealthcare.com for additional information.  

Previous Events
January 8, 2017, San Francisco
Biotech Showcase 2017 – TPP Healthcare Education Forum
October 7, 2015, San Diego
AdvaMed 2015 – TPP China Forum
January 25, 2015, San Francisco
23rd Annual Medical Device Conference 2015 – TPP China Forum
January 14, 2015, San Francisco
JP Morgan Healthcare Week 2015 – TPP 1-on-1 Partnering

Why Attend our 1-on-1 Partnering Events and Educational Forums?

TPP Forums are first-of-its-kind events – congregating 100s of Chinese dealmakers and Western Innovators together in one room. Fully vetted with pre-event diligence, coordinated and prearranged by our team of bilingual analysts and onsite independent PhD translators and cross-border business specialists at every event – our mark is always made.

We invite those who are serious about their business and growth potential – whether that be product, drug or investment portfolio related. Public pharma companies are seeking groundbreaking technologies to help them stand out from their peers. Healthcare funds have billions of US dollars under management and a mandate to invest in cross-border deals. Join us as we continue this path to a smarter healthcare business.